Oflomist-OZ

Oflomist-OZ

Ofloxacin 200 mg + Ornidazole 500 mg

200 mg + 500 mg

Indications

  • Acute gastroenteritis and traveller’s diarrhoea with mixed bacterial/protozoal aetiology
  • Pelvic inflammatory disease (PID) and gynaecological infections
  • Amoebiasis, giardiasis, and trichomoniasis
  • Intra-abdominal infections requiring combined aerobic–anaerobic coverage

Contraindications

  • Known hypersensitivity to fluoroquinolones or nitroimidazoles
  • History of tendon disorders associated with quinolone use; epilepsy
  • Pregnancy (especially first trimester) and breast-feeding — consult physician

Side effects

  • Nausea, vomiting, and metallic taste (Ornidazole-related)
  • Dizziness, headache, and photosensitivity (Ofloxacin-related)
  • QT prolongation risk — caution with concurrent QT-prolonging drugs

Important: This information is provided for educational purposes only and is not a substitute for professional medical advice. Please consult a Registered Medical Practitioner before starting, stopping, or changing any medication. Manufactured and marketed under Indian DCGI regulations.

Related Products

More from the same therapeutic area.